Task order no. 0001 - medicinal chemistry support program for therapeutic development (mcsp

Active Awarded Last action

Contract number
HHSN27100001
Awardee
Awarding agency
Obligated
$173,705

Award facts

Opportunity
Contract value 89% obligated
  • $173,705.00 Current, with exercised options
  • $195,028.00 Potential, with all options
Completion date 86% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Albany, NY 12212, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00009 $21,111
Exercise an Option P00008 $20,906
Funding Only Action P00007 -$1
Exercise an Option P00006 $20,521
Exercise an Option P00005 $19,924
Exercise an Option P00004 $19,343
Exercise an Option P00002 · Medicinal chemistry support program for therapeutic development (mcsp) - PA1: tech transfer, storage handling and distribution, access training and IT… $18,233
Exercise an Option P00001 $17,702
Modification $17,186
Exercise an Option P00003 · Medicinal chemistry support program for therapeutic development (mcsp) - performance area 1: tech transfer, storage handling and distribution, access training… $18,780

About this award

The National Institute of Neurological Disorders and Stroke issued a delivery order to Curia Global Inc. (doing business as Amri) on March 16, 2018, with a ceiling value of $195,028.00 for medicinal chemistry support under the Medicinal Chemistry Support Program for Therapeutic Development.

The order covers Performance Area 1: tech transfer, storage, handling, and distribution of compounds; access training; and IT security relevant to an existing compound repository. Place of performance is Albany, NY. The order is firm fixed price with an ultimate completion date of March 15, 2028. No set-aside was used.

Quick answers

Who was awarded contract HHSN27100001?

HHSN27100001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 16, 2018.

How much is contract HHSN27100001 worth?

The government has obligated $173,705 on HHSN27100001. Its potential value, with all options, is $195,028.

Which agency awarded contract HHSN27100001?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Is contract HHSN27100001 an order under another contract?

Yes. HHSN27100001 is a delivery order under HHSN271201800001I, an indefinite delivery contract.

Was contract HHSN27100001 competed?

The extent of competition for HHSN27100001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award